Lack of reliability of nanotechnology in the of free plasma DNA in samples of patients with prostate cancer

BACKGROUND: Several studies seek biological markers that give diagnostic and degree of tumor development. The aim of this study was to validate the determination of plasma DNA using nanotechnology (Nanovue™-NV) in samples of 80 patients with prostate cancer. METHODS: Blood samples of 80 patients of...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreno, Ricardo, Delgado, Pamela O, Coelho, Patrícia G, Marsicano, Sarah R, Boas, Viviane AV, Azzalis, Ligia A, Junqueira, Virgínia BC, Rocha, Katya C, de Abreu, Luiz Carlos, Valenti, Vitor E, Drezzet, Jefferson, Pereira, Edimar Cristiano, Fonseca, Fernando LA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605229/
https://www.ncbi.nlm.nih.gov/pubmed/23311763
http://dx.doi.org/10.1186/1755-7682-6-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605229/
https://www.ncbi.nlm.nih.gov/pubmed/23311763
http://dx.doi.org/10.1186/1755-7682-6-2

Ejemplares similares